Walker Magalhães LAHMANN,Hilton Oliveira dos SANTOS FILHO,Iara Silva Brauer MANTOVANI,Cristiano Martins VELOSO,Simone Batista de OLIVEIRA,Fabiana Lima CARVALHO
申请号：
US15035404
公开号：
US20160287558A1
申请日:
2014.11.07
申请国别(地区):
US
年份:
2016
代理人:
摘要：
The present invention broadly relates to oral dosage forms for therapeutic use in the prevention of cardiovascular and cerebrovascular diseases in mammals, preferably in humans. Particularly, the invention relates to a tablet comprising (a) one or more HMG-CoA reductase inhibitors, (b) one or 5 more antagonists of angiotensin II receptors and (c) one or more thiazide diuretics.
